“Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results”: Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-a in MS (SPECTRIMS) Study Group (2001):

“Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results”: Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-a in MS (SPECTRIMS) Study Group (2001):

-the primary outcome, time to confirmed progression in disability, was not significantly affected by treatment (p: 0.146)

Published by

kaylin bower

Multiple Sclerosis Research Repository